Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1 ; volume:9 ; number:1 ; day:23 ; month:4 ; year:2018 ; pages:1-11 ; date:12.2018
Nature Communications ; 9, Heft 1 (23.4.2018), 1-11, 12.2018
- Creator
-
Zhu, Yinghua
- Contributor
-
Liu, Yujie
Zhang, Chao
Chu, Junjun
Wu, Yanqing
Li, Yudong
Liu, Jieqiong
Li, Qian
Li, Shunying
Shi, Qianfeng
Jin, Liang
Zhao, Jianli
Yin, Dong
Efroni, Sol
Su, Fengxi
Yao, Herui
Song, Erwei
Liu, Qiang
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-03951-0
- URN
-
urn:nbn:de:101:1-2018062121372555423761
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Yinghua
- Liu, Yujie
- Zhang, Chao
- Chu, Junjun
- Wu, Yanqing
- Li, Yudong
- Liu, Jieqiong
- Li, Qian
- Li, Shunying
- Shi, Qianfeng
- Jin, Liang
- Zhao, Jianli
- Yin, Dong
- Efroni, Sol
- Su, Fengxi
- Yao, Herui
- Song, Erwei
- Liu, Qiang
- SpringerLink (Online service)
Other Objects (12)
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
2-methoxyestradiol sensitizes tamoxifen-resistant MCF-7 breast cancer cells via downregulating HIF-1α
The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
TROP2 methylation and expression in tamoxifen-resistant breast cancer
Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer
CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression